Myoclonus associated with megestrol acetate
Journal of Geriatric Neurology · 2023
DOI: 10.53991/jgn.2023.00038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Geriatric Neurology, 2023. Verfasst von Su Min Park und 1 weiteren Autor:innen. Die Arbeit nennt 9 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Myoclonus is a clinical sign characterized by brief, involuntary, jerky contraction or lapse of contraction of a muscle or a group of muscles, which can be associated with cerebral disorders, epileptic disorders, and drugs. Megestrol acetate (MGA) is a synthetic derivative of progestin, which has been widely used in clinical practice for increasing appetite in patients with severe anorexia associated with malignancies. We experienced a 68-year-old female patient who experienced myoclonus after administration of MGA and herein report the case. Our case indicated that MGA may be a cause of reversible myoclonus. Cryptogenic myoclonus can be encountered in patients with wasting syndromes associated with malignancies. It may be a cause of unexplained myoclonus in such patients.
Zitieren
APA
Park, S. M., & Lee, J. (2023). Myoclonus associated with megestrol acetate. Journal of Geriatric Neurology. https://doi.org/10.53991/jgn.2023.00038
Vancouver
Park SM, Lee J. Myoclonus associated with megestrol acetate. Journal of Geriatric Neurology. 2023. doi:10.53991/jgn.2023.00038
BibTeX
@article{Park2023,
author = {Park, Su Min and Lee, Jung-Ju},
title = {Myoclonus associated with megestrol acetate},
journal = {Journal of Geriatric Neurology},
year = {2023},
doi = {10.53991/jgn.2023.00038}
}
EUVIMED